Infant Colic Probiotics: What New Studies Actually Show
The clinical evidence on infant colic and probiotics suggests a real but selective benefit: some trials and meta-analyses show reduced crying time, while the effect is strongest in breastfed infants and much less certain in formula-fed babies. The best-supported strain in the literature is Lactobacillus reuteri DSM 17938, but overall results remain strain-specific, evidence quality is often low to moderate, and safety data so far have not raised major concerns in healthy infants.
What the studies show
Clinical research has moved from small early trials to larger systematic reviews, and the overall pattern is now clearer: probiotics do not appear to "cure" colic, but they can shorten crying episodes in some infants, usually by a modest amount measured in minutes per day rather than hours. A 2024 systematic review and meta-analysis reported an average reduction of 51 minutes of crying per day across included trials, with the biggest reduction seen in exclusively breastfed infants.
Earlier randomized trials also pointed in the same direction, especially for breastfed infants. In one frequently cited placebo-controlled study, infants receiving probiotic treatment cried less by day 21 than those given placebo, and the difference appeared within the first week. Another trial found that a specific probiotic formulation reduced crying by at least half in 80% of treated infants versus 33% of controls, underscoring that the "right" strain may matter more than the broad label of probiotic.
How researchers measured benefit
Most clinical studies on crying time use parent diaries, daily duration logs, and responder outcomes such as "50% reduction in crying." That makes the field practical but imperfect, because colic is hard to define consistently and caregiver reporting can vary. Even so, the direction of effect across many trials has been similar enough that pooled analyses now support a genuine signal rather than a one-off result.
One major review published in 2020 found that probiotic intervention reduced crying duration with a standardized mean difference of -2.012 and increased the chance of at least a 50% reduction in crying by nearly twofold compared with controls. A later Cochrane review focused on prevention found no clear evidence that probiotics prevent colic from occurring, but it did find a reduction in crying time and no clear safety differences versus placebo.
Which strains look promising
Not all probiotics behave the same way, and the evidence is strongest for a small number of strains rather than the category as a whole. The most studied agent is Lactobacillus reuteri DSM 17938, which repeatedly appears in infant colic trials and subgroup analyses. Some newer studies also suggest benefit from Bifidobacterium animalis subsp. lactis BB-12, but the evidence base is smaller and less mature.
| Study type | Main finding | Most relevant caveat |
|---|---|---|
| Randomized trial in breastfed infants | Reduced crying time versus placebo by day 21 | Small sample size and strong placebo-related improvement |
| 2020 meta-analysis | Lower crying duration and higher chance of 50% improvement | Mixed strains and heterogeneous study methods |
| 2024 systematic review | Average reduction of 51 minutes of crying per day | Benefit clearer in breastfed infants than formula-fed infants |
| Cochrane prevention review | Little or no effect on colic occurrence, but less crying time | Low-certainty evidence and limited prevention data |
Who seems most likely to benefit
The subgroup signal is one of the most important findings in the literature: exclusively breastfed infants consistently show the clearest response, while the evidence is weaker for formula-fed infants and for babies born by caesarean section. That pattern has led many reviewers to think that gut microbiome differences may partly explain why some infants respond better than others.
In the 2024 review, the reduction in crying was 74.28 minutes per day for exclusively breastfed infants and 64.66 minutes per day for Lactobacillus reuteri DSM 17938 specifically, which is a notable signal even if the underlying studies were not all identical. The same review found limited evidence for formula-fed infants and caesarean-born infants, so broad claims about universal effectiveness would overstate the data.
Safety and limitations
Safety data are reassuring overall, especially in otherwise healthy infants, and the Cochrane review found no meaningful difference in serious adverse events between probiotic and placebo groups. That said, "safe in studies" does not mean every commercial product is equivalent, because product quality, strain identity, and dose can differ from one bottle to another.
The biggest limitation in the literature is heterogeneity: studies use different strains, doses, durations, feeding patterns, and colic definitions. Another limitation is that crying naturally improves over time, so even a good placebo-controlled trial has to separate the treatment effect from the infant's normal developmental trajectory.
What this means for parents
For a parent reading the evidence today, the most accurate takeaway is that probiotics are a reasonable discussion point, not a guaranteed fix. The strongest case is for a trial of a studied strain, especially breastfed infants, when colic is otherwise typical and there are no red-flag symptoms suggesting another diagnosis.
It is also important to match expectations to the evidence: a response, when it happens, is often a reduction in crying duration rather than complete elimination of colic. Parents and clinicians should also check whether the specific strain used in a study is actually listed on the product label, because probiotic effects are strain-dependent and not interchangeable.
Clinical context
Infant colic is common, distressing, and usually self-limited, which is why even modest treatment effects matter in practice. The research history shows a steady evolution from early single-trial enthusiasm to more nuanced meta-analytic conclusions: probiotics may help, but only for some infants and only with some strains.
That nuance is especially important for clinicians counseling families. The evidence supports a cautious, targeted approach rather than a blanket recommendation for every baby with colic.
- Confirm the colic pattern and rule out warning signs such as fever, vomiting, poor weight gain, blood in stool, or lethargy.
- Consider whether the baby is breastfed, because the best evidence of benefit is in that group.
- If trying a probiotic, use a strain that has been studied in colic, not a generic product label.
- Track crying time for at least 1 to 2 weeks, since some trials saw improvement early but not instantly.
- Stop if the product is poorly tolerated or if the baby's symptoms suggest a different diagnosis.
"The signal is real, but the benefit is strain-specific and most convincing in breastfed infants."
In practical terms, the science now supports a careful, evidence-based trial of selected probiotics for infant colic rather than a sweeping promise that all probiotic products will work.
What are the most common questions about Infant Colic Probiotics What New Studies Actually Show?
Do probiotics work for infant colic?
They can help reduce crying time in some infants, but the effect is not universal and appears strongest in breastfed babies.
Which probiotic has the best evidence?
Lactobacillus reuteri DSM 17938 has the most consistent trial history, although other strains such as Bifidobacterium animalis subsp. lactis BB-12 also have supportive data.
Are probiotics safe for babies with colic?
In the studies reviewed so far, probiotics have not shown a clear safety signal in healthy infants, and serious adverse events were not more common than with placebo.
Should formula-fed infants take probiotics for colic?
The evidence is weaker in formula-fed infants, so the benefit is less certain than in breastfed infants.
Do probiotics prevent colic?
Current evidence does not show clear prevention of colic, even though they may reduce crying time once colic is present or developing.